Genetic Counselling in DMD

Introduction and Etiology

Down syndrome is the most common chromosomal disorder in humans, occurring in approximately 1:800 to 1:1000 live births.
Genetic counselling fundamentally relies on obtaining a chromosomal analysis (karyotype) of the child to determine the exact etiology, which dictates recurrence risks.
Etiological variants include free trisomy 21 caused by meiotic nondisjunction (95%), chromosomal translocations mostly involving chromosomes 21 and 14 (3-4%), and chromosomal mosaicism (1-2%).
Advanced maternal age is a primary risk factor for nondisjunction, with risk rising exponentially from 1:350 at 35 years to 1:100 at 40 years.

The condition results from a gene dosage effect due to the overexpression of approximately 300 genes located on chromosome 21.
Overexpressed genes include APP, DYRK1A, SOD1, and RCAN1.
This genetic imbalance leads to disrupted neurogenesis, oxidative stress, immune dysregulation, and cardiac morphogenesis defects.

Confirm the diagnosis using karyotype or Fluorescence In Situ Hybridization (FISH) to provide a rapid result within 24-48 hours.
Obtain parental karyotypes if a translocation is identified or suspected.
Deliver the news in a private setting with both parents present, utilizing the SPIKES protocol for breaking bad news,.
Use simple, positive language that provides hope, allowing sufficient time for parents to process the information and ask questions.
Emphasize that the genetic event is a random occurrence and not due to parental fault.

Outline known medical problems and assure parents that routine screening will be implemented to manage these risks.
Highlight common anomalies, including congenital heart disease (Atrioventricular Septal Defect in 40%), gastrointestinal atresias, hearing and vision defects, and hypothyroidism.
Discuss the increased risk of transient myeloproliferative disorder and leukemia.
Emphasize the importance of early intervention programs, including early stimulation, physiotherapy, occupational therapy, and speech therapy.
Reassure parents that most children with Down syndrome are trainable, adjust well socially, are highly affectionate, and can achieve semi-independence with supported employment in adulthood,.
Discuss long-term complications, such as early-onset Alzheimer disease pathology, which affects almost 100% of patients by 40 years of age.

Explicit details regarding recurrence risk must only be discussed after a definitive chromosomal analysis is available.
Risk assessment is heavily dependent on maternal age and the specific cytogenetic cause.

Cytogenetic Variant	Parental Carrier Status	Recurrence Risk
Free Trisomy 21	Not Applicable	~1% or maternal age-specific risk, whichever is higher,
Translocation (e.g., 14;21)	Maternal Carrier	10-15% risk per pregnancy,
Translocation (e.g., 14;21)	Paternal Carrier	1-5% risk (due to sperm competition),
Translocation 21;21	Either Parent Carrier	100% risk in all viable fetuses,
Translocation	De Novo	~1% risk
Mosaic Trisomy 21	Not Applicable	~1% risk, unless gonadal mosaicism is present

Counsel parents on options for prenatal screening and diagnosis in all future pregnancies.
First-trimester combined screening utilizes Nuchal Translucency (NT), Pregnancy-Associated Plasma Protein A (PAPP-A), and free beta-hCG to achieve an 85-90% detection rate,.
Non-Invasive Prenatal Testing (NIPT) analyzes cell-free fetal DNA from maternal blood after 10 weeks of gestation, offering >99% sensitivity with a false-positive rate of <0.1%,.
Positive screening results must be confirmed with invasive diagnostic procedures.
Chorionic Villus Sampling (CVS) can be performed at 10-13 weeks of gestation, carrying a 0.5-1% miscarriage risk,.
Amniocentesis is performed at 15-20 weeks of gestation and represents the gold standard with a 0.1-0.3% procedure-related loss risk.
Preimplantation Genetic Testing (PGT) combined with In Vitro Fertilization (IVF) is the preferred reproductive option if a parent is identified as a balanced translocation carrier.

Address emotional reactions, including shock, denial, guilt, and grief.
Discourage discussions regarding institutionalization unless explicitly asked by the parents.
Connect families with support networks, such as the Down Syndrome Federation of India.
Inform parents about government schemes, financial assistance for therapies, and disability certification.